Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

NCT03239561 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: [18F]MNI-1020

Sponsor

Janssen Research & Development, LLC